共 416 条
[1]
Ettinger DS(2010)Non-small cell lung cancer J Natl Compr Canc Netw 8 740-801
[2]
Akerley W(2010)Changes in the Use and Costs of Diagnostic Imaging Among Medicare Beneficiaries With Cancer, 1999–2006 JAMA 303 1625-1631
[3]
Bepler G(2011)The role of positron emission tomography in management of small cell lung cancer Lung Cancer 73 121-126
[4]
Blum MG(2000)A combined PET/CT scanner for clinical oncology J Nucl Med 41 1369-1379
[5]
Chang A(2010)Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches J Nucl Med 51 401-412
[6]
Cheney RT(2000)Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies J Cancer Res Clin Oncol 126 549-559
[7]
Dinan MA(2006)How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study Eur J Nucl Med Mol Imaging 33 697-702
[8]
Curtis LH(2004)Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images Lung Cancer 45 19-27
[9]
Hammill BG(2003)Value of FDG-PET in the management of non-small cell lung cancer Eur J Radiol 45 49-59
[10]
Patz EF(2006)The future in diagnosis and staging of lung cancer: positron emission tomography Respiration 73 267-276